Alison H. Harrill

1.7k total citations
33 papers, 1.1k citations indexed

About

Alison H. Harrill is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Alison H. Harrill has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Pharmacology and 11 papers in Cancer Research. Recurrent topics in Alison H. Harrill's work include Drug-Induced Hepatotoxicity and Protection (10 papers), MicroRNA in disease regulation (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Alison H. Harrill is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (10 papers), MicroRNA in disease regulation (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Alison H. Harrill collaborates with scholars based in United States, France and United Kingdom. Alison H. Harrill's co-authors include Paul B. Watkins, Ivan Rusyn, David W. Threadgill, Daniel M. Gatti, Pamela K. Ross, J. Scott Eaddy, Daniel J. Antoine, Kimberly A. McAllister, Yuching Yang and Scott Q. Siler and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Environmental Health Perspectives and Genome Research.

In The Last Decade

Alison H. Harrill

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison H. Harrill United States 19 444 387 198 178 151 33 1.1k
Xinsheng Gu China 16 310 0.7× 472 1.2× 183 0.9× 116 0.7× 71 0.5× 31 1.1k
Kajsa P. Kanebratt Sweden 13 556 1.3× 412 1.1× 77 0.4× 168 0.9× 271 1.8× 19 1.4k
Kevin B. Park United Kingdom 12 618 1.4× 473 1.2× 307 1.6× 304 1.7× 291 1.9× 13 1.6k
Chao Guo China 19 167 0.4× 520 1.3× 196 1.0× 147 0.8× 54 0.4× 53 1.1k
Robert Elsby United Kingdom 20 551 1.2× 367 0.9× 108 0.5× 109 0.6× 94 0.6× 25 1.6k
Nelson Varela Chile 17 236 0.5× 535 1.4× 145 0.7× 464 2.6× 109 0.7× 59 1.3k
Andreas Benesic Germany 17 449 1.0× 243 0.6× 73 0.4× 253 1.4× 287 1.9× 30 1.1k
Björn Glinghammar Sweden 18 217 0.5× 417 1.1× 150 0.8× 189 1.1× 131 0.9× 27 956
Hongbing Wang United States 20 655 1.5× 384 1.0× 95 0.5× 98 0.6× 42 0.3× 55 1.4k

Countries citing papers authored by Alison H. Harrill

Since Specialization
Citations

This map shows the geographic impact of Alison H. Harrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison H. Harrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison H. Harrill more than expected).

Fields of papers citing papers by Alison H. Harrill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison H. Harrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison H. Harrill. The network helps show where Alison H. Harrill may publish in the future.

Co-authorship network of co-authors of Alison H. Harrill

This figure shows the co-authorship network connecting the top 25 collaborators of Alison H. Harrill. A scholar is included among the top collaborators of Alison H. Harrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison H. Harrill. Alison H. Harrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weitekamp, Chelsea A., Katie Paul Friedman, Alison H. Harrill, et al.. (2025). Quantitative and qualitative concordance between clinical and nonclinical toxicity data. Toxicological Sciences. 206(2). 253–272. 1 indexed citations
2.
Harrill, Alison H. & Alison P. Sanders. (2020). Urinary MicroRNAs in Environmental Health: Biomarkers of Emergent Kidney Injury and Disease. Current Environmental Health Reports. 7(2). 101–108. 5 indexed citations
3.
Lyn‐Cook, Lascelles E., Daniel M. Gatti, Philip R. Mayeux, et al.. (2020). Nitrosative Stress and Lipid Homeostasis as a Mechanism for Zileuton Hepatotoxicity and Resistance in Genetically Sensitive Mice. Toxicological Sciences. 175(2). 220–235. 10 indexed citations
4.
Harrill, Alison H. & Kimberly A. McAllister. (2017). New Rodent Population Models May Inform Human Health Risk Assessment and Identification of Genetic Susceptibility to Environmental Exposures. Environmental Health Perspectives. 125(8). 86002–86002. 34 indexed citations
5.
Harrill, Alison H., et al.. (2016). MicroRNA Biomarkers of Toxicity in Biological Matrices. Toxicological Sciences. 154(1). 196–196.
6.
Miousse, Isabelle R., A Currie, Kaushik Datta, et al.. (2015). Importance of investigating epigenetic alterations for industry and regulators: An appraisal of current efforts by the Health and Environmental Sciences Institute. Toxicology. 335. 11–19. 21 indexed citations
7.
Shi, Qiang, Xi Yang, William B. Mattes, et al.. (2015). Circulating Mitochondrial Biomarkers for Drug-Induced Liver Injury. Biomarkers in Medicine. 9(11). 1215–1223. 13 indexed citations
8.
Church, Rachel J., Monicah A. Otieno, J. Eric McDuffie, et al.. (2015). Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in Rats. Toxicological Sciences. 150(1). 3–14. 26 indexed citations
9.
Church, Rachel J., Daniel M. Gatti, Thomas Urban, et al.. (2014). Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice. Food and Chemical Toxicology. 76. 19–26. 69 indexed citations
10.
Church, Rachel J., Hong Wu, Merrie Mosedale, et al.. (2014). A Systems Biology Approach Utilizing a Mouse Diversity Panel Identifies Genetic Differences Influencing Isoniazid-Induced Microvesicular Steatosis. Toxicological Sciences. 140(2). 481–492. 42 indexed citations
11.
Singhal, Rohit, et al.. (2014). Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine. BMC Pharmacology and Toxicology. 15(1). 42–42. 34 indexed citations
12.
Weng, Zuquan, Peng Zhou, William F. Salminen, et al.. (2014). Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria. Biochemical and Biophysical Research Communications. 443(3). 1097–1104. 28 indexed citations
13.
Thulin, Petra, Gunnar Nordahl, Marcus Gry, et al.. (2013). Keratin‐18 and micro RNA ‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts. Liver International. 34(3). 367–378. 89 indexed citations
14.
Harrill, Alison H., Kristina DeSmet, Kristina Wolf, et al.. (2012). A Mouse Diversity Panel Approach Reveals the Potential for Clinical Kidney Injury Due to DB289 Not Predicted by Classical Rodent Models. Toxicological Sciences. 130(2). 416–426. 44 indexed citations
15.
Harrill, Alison H., James Roach, J. Scott Eaddy, et al.. (2012). The Effects of Heparins on the Liver: Application of Mechanistic Serum Biomarkers in a Randomized Study in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 92(2). 214–220. 89 indexed citations
16.
Woodhead, Jeffrey L., Brett A. Howell, Yuching Yang, et al.. (2012). An Analysis of N-Acetylcysteine Treatment for Acetaminophen Overdose Using a Systems Model of Drug-Induced Liver Injury. Journal of Pharmacology and Experimental Therapeutics. 342(2). 529–540. 63 indexed citations
17.
Gatti, Daniel M., Alison H. Harrill, Fred A. Wright, David W. Threadgill, & Ivan Rusyn. (2009). Replication and narrowing of gene expression quantitative trait loci using inbred mice. Mammalian Genome. 20(7). 437–446. 16 indexed citations
18.
Harrill, Alison H., Paul B. Watkins, Stephen Su, et al.. (2009). Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Research. 19(9). 1507–1515. 136 indexed citations
19.
Harrill, Alison H., Pamela K. Ross, Daniel M. Gatti, David W. Threadgill, & Ivan Rusyn. (2009). Population-Based Discovery of Toxicogenomics Biomarkers for Hepatotoxicity Using a Laboratory Strain Diversity Panel. Toxicological Sciences. 110(1). 235–243. 68 indexed citations
20.
Harrill, Alison H. & Ivan Rusyn. (2008). Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity. Expert Opinion on Drug Metabolism & Toxicology. 4(11). 1379–1389. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026